Equity Research firms currently have a positive stance on shares of Exact Sciences Corporation (NASDAQ:EXAS). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.10. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $18.33 on a short term basis.
At the time of writing, the stock was trading at $18.75. This represents a change from the opening price of -2.16%. In terms of performance, year to date, the stock is 104.23%. The monthly stock performance comes in at 3.60%. For the quarter, shares are performing at 58.94%. Weekly performance analysis shows the equity at -3.03%.
In taking a look at technical levels, shares are trading -2.08% away from the 50 day simple moving average and 77.54% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -17.74% away from it’s 52- week high and 301.61% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Exact Sciences Corporation’s RSI stands at 45.91. In looking at volatility levels, the shares saw weekly volatility of 6.37% and 5.24% over the past month.